European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Director General ‘Welcomes’ Costa Rica Call For Pooled Rights To COVID-19 Treatments; G-20 Pledges Broad Support To Emergency Response 26/03/2020 Elaine Ruth Fletcher World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has welcomed the call by Costa Rica’s President, Carlos Alvarado Quesada, for WHO to launch an initiative that would “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.” “I welcome his initiative & call for pooled rights […] Continue reading -> Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Blood Plasma Of Recovered COVID-19 Patients Approved By US FDA For Investigational Use As Treatment 25/03/2020 Grace Ren The US Food and Drug Administration granted investigational emergency use approval for convalescent blood plasma as a potential COVID-19 treatment on Tuesday. Cloned antibodies from recovered COVID-19 patients showed impressive ability to neutralize SARS-CoV-2, the virus behind the disease, in cell cultures, according to a paper published Wednesday on the preprint server BioRxiv. Two of […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Protective Equipment Manufacturing Must Increase By 80-100 Times During COVID-19 Pandemic; WHO Projects 26 Million Healthcare Workers In Need 20/03/2020 Grace Ren Manufacturing of personal protective equipment (PPE) for the COVID-19 pandemic response should be scaled up by 80 to 100 times to meet the projected needs of the healthcare workforce, the World Health Organization said on Friday. Amid a growing PPE shortage crisis in hotspots like Italy, the United States, and Iran, some 26 million healthcare […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Worldwide Shortage Of COVID-19 Test Agents Plagues Health Systems – Even As Infections Surpass 200,000 18/03/2020 Elaine Ruth Fletcher A worldwide shortage of chemical reagents needed for COVID-19 testing has emerged, World Health Organization officials admitted on Wednesday – even as the number of confirmed cases of the novel coronavirus worldwide surpassed the 200,000 mark. Reports of shortages come days after WHO’s Director General Dr Tedros Adhanom Ghebreyesus issued an urgent appeal to countries […] Continue reading -> Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts
Costs Of COVID-19 Tests Could Be Limiting Scale-Up in Europe; WHO Says ‘Herd Immunity’ Approach Lacks Evidence Base 17/03/2020 Elaine Ruth Fletcher & Grace Ren A leading medicines access group in Europe has issued a protest against the high price of COVID-19 tests in France, amidst rising concerns that the cost of the diagnostic test may also be limiting the number of people who are being tested in Europe – the new global epicenter of the COVID-19 pandemic. In France, […] Continue reading -> Posts navigation Older postsNewer posts